The project, which will be conducted by URMC’s Center for Health + Technology, seeks to create objective, digital tools that can provide a clearer picture of how Huntington’s disease advances, ...

The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.

Exciting results for MeiraGTx Holdings plc's GAD gene therapy for Parkinson's Disease, with promising phase 1/2 data and ...

MALVERN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical ...

Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ...

MeiraGTx Holdings (NASDAQ:MGTX) added ~14% in the premarket on Tuesday after the New York-based biotech announced promising ...

Shares in MeiraGTx rose after the company said it received positive data in a clinical bridging study of AAV-GAD for the treatment of Parkinson's disease. Shares were up nearly 14% in premarket ...

Norton Healthcare is now able to offer patients suffering from Essential Tremors and Parkinson's Disease some relief. The ...

Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ...

Recent research zooms in on the brain's own 'waste-disposal' system, with the aim of uncovering potential strategies to ...